Neulasta

Coherus, sharpening immuno-oncology focus, sells another biosimilar for over $500M
BioPharma Dive
Wed, 12/4/24 - 10:59 am
Coherus Biosciences
immuno-oncology
biosimilars
Amgen
Neulasta
Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector
Fierce Pharma
Mon, 09/25/23 - 07:56 pm
Coherus Biosciences
Neulasta
biosimilars
FDA
Junshi Biosciences
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Pharmaceutical Business Review
Fri, 02/17/23 - 09:44 am
Fresenius Kabi
Stimufend
pegfilgrastim
biosimilars
Neulasta
Amgen
cancer
Amgen's Neulasta gains another biosimilar competitor as sales slip
Endpoints
Thu, 09/8/22 - 04:35 pm
Amgen
Neulasta
Fresenius Kabi
biosimilars
FDA
Stimufend
Amneal scores third biosimilar approval in three months
Biopharma Reporter
Tue, 05/31/22 - 10:31 am
Amneal
FDA
biosimilars
pegfilgrastim
Fylnetra
Amgen
Neulasta
Amgen's Neulasta banner draws OPDP’s second letter of 2021
RAPS.org
Wed, 07/14/21 - 10:54 pm
Amgen
Neulasta
FDA
OPDP
advertising
If Biosimilars Are Struggling, Someone Forgot to Tell Coherus BioSciences
Motley Fool
Tue, 11/19/19 - 02:34 pm
biosimilars
FDA
Coherus Biosciences
Neulasta
Amgen
It took a 3-year struggle, but Novartis finally gets a green light on their copycat to Amgen's big blockbuster
Endpoints
Tue, 11/5/19 - 10:23 am
Novartis
FDA
Amgen
Neulasta
biosimilars
Ziextenzo
cancer
Under copycat attack, Amgen punches back with its own biosimilars
Fierce Pharma
Tue, 10/29/19 - 10:48 pm
Amgen
biosimilars
generics
Sensipar
Neulasta
Neupogen
A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering
Investors Business Daily
Sat, 10/5/19 - 02:17 pm
Coherus Biosciences
Novartis
Udenyca
Neulasta
biosmilars
Coherus' Neulasta biosimilar surprises with strong early uptake
Biopharma Dive
Mon, 04/8/19 - 05:44 pm
Coherus Biosciences
Neulasta
biosimilars
Udenyca
Amgen
Sandoz resubmission puts Amgen's Neulasta at further risk of competition
Biopharma Dive
Wed, 04/3/19 - 09:31 pm
FDA
Novartis
biosimilars
Sandoz
Amgen
Neulasta
Spectrum yanks marketing application for Neulasta rival after FDA demands more data
Endpoints
Fri, 03/15/19 - 11:04 am
Spectrum Pharmaceuticals
FDA
lung cancer
poziotinib
Neulasta
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Reuters
Fri, 11/9/18 - 12:03 pm
Coherus Biosciences
Amgen
biosimilars
Neulasta
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Mon, 11/5/18 - 09:56 am
Coherus
Neulasta
Mylan
biosimilars
Amgen
Mylan biosimilar to stress test Amgen Neulasta franchise, analyst predicts
Biopharma Dive
Mon, 09/17/18 - 03:14 pm
Amgen
Neulasta
biosimilars
Could Amgen soften the Neulasta biosimilar blow with an Alexion buy?
Fierce Pharma
Mon, 07/16/18 - 10:34 pm
Amgen
biosimilars
Neulasta
Alexion
M&A
Amgen's $3.9B Neulasta to face U.S. biosim 'in the coming weeks' with Mylan approval
Fierce Pharma
Tue, 06/5/18 - 12:02 pm
FDA
Fulphila
Mylan Labs
biosimilars
Amgen
Neulasta
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
CP Wire
Thu, 05/3/18 - 11:11 pm
Coherus Biosciences
Neulasta
CHS-1701
Mylan
Biocon
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
Thu, 05/3/18 - 02:45 pm
Coherus Biosciences
Neulasta
CHS-1701
Mylan
Biocon

Pages